Michael Petusky Analyst Performance

Research Analyst at Barrington Research

Michael Petusky is a stock analyst at Barrington Research focused in the medical sector, covering 18 publicly traded companies. Over the past year, Michael Petusky has issued 46 stock ratings, including strong buy, buy, and hold recommendations. While full access to Michael Petusky's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Michael Petusky's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 92 Last 10 Years
Buy Recommendations: 90.11% 82 Buy Ratings
Companies Covered: 18 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	1.1%	1 ratings
Buy	89.0%	81 ratings
Hold	9.9%	9 ratings
Sell	0.0%	0 ratings

Out of 91 total stock ratings issued by Michael Petusky at Barrington Research, the majority (89.0%) have been Buy recommendations, followed by 9.9% Hold and 1.1% Strong Buy.

Best & Worst Calls

Best Call
0000.0%
TVTY
Apr 2016
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
OPK
Sep 2021
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	72.2% of companies on NASDAQ	13 companies
NYSE	27.8% of companies on NYSE	5 companies

Michael Petusky, an analyst at Barrington Research, currently covers 18 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 14 companies	77.8%
	Business Services 1 company	5.6%
	Consumer Discretionary 1 company	5.6%
	Utilities 1 company	5.6%
	Miscellaneous 1 company	5.6%

Michael Petusky of Barrington Research specializes in stock coverage within the Medical sector, with additional focus on Business Services and Consumer Discretionary companies.

Coverage Industries

Industry	Percentage
MED/DENTAL - SUPP 3 companies	16.7%
MED PRODUCTS 3 companies	16.7%
MED INSTRUMENTS 2 companies	11.1%
MED - OUTP/HM CRE 2 companies	11.1%
MED - BIOMED/GENE 1 company	5.6%
TECHNOLOGY SERVICES 1 company	5.6%
MEDICAL SERVICES 1 company	5.6%
TRANSPORTATION SERVICES 1 company	5.6%
ELECTROMEDICAL EQUIPMENT 1 company	5.6%
BOTTLED & CANNED SOFT DRINKS 1 company	5.6%
MISCELLANEOUS HEALTH & ALLIED SERVICES 1 company	5.6%
Miscellaneous 1 company	5.6%

About Michael Petusky

Michael Petusky joined Barrington Research in 2014 as Managing Director & Senior Investment Analyst covering Healthcare Services and focusing currently on the pharmacy, home infusion, rehabilitation, chronic care management and wellness, and senior housing, as well as Dental Services and select Medical Device companies. Prior to joining Barrington Research, Mr. Petusky covered healthcare services stocks and select medical device ideas for Noble Financial Group (2007-2014), Thompson Davis & Co. (2002-2007), and Branch Cabell, and its successor firms (1995-2002). Mr. Petusky has been quoted in national publications such as Business Week, Investor’s Business Daily, Smart Money Magazine, and The Washington Post. In 2010, he received a StarMine analyst award for his stock-picking ability among analysts covering Healthcare Services. Mr. Petusky has a B.B.A. (Finance-concentration) from the University of Richmond (1991) and also holds the Chartered Financial Analyst designation.

Follow on LinkedIn

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
OFIX Orthofix Medical	9/23/2025	Reiterated Rating	$14.98	$17.00	Outperform
OPCH Option Care Health	9/23/2025	Reiterated Rating	$27.67	$38.00	Outperform
MMSI Merit Medical Systems	9/23/2025	Reiterated Rating	$83.46	$103.00	Outperform
LMAT LeMaitre Vascular	9/23/2025	Reiterated Rating	$91.55	$95.00	Outperform
HSIC Henry Schein	9/23/2025	Reiterated Rating	$69.24	$78.00	Outperform
HAE Haemonetics	9/23/2025	Reiterated Rating	$51.44	$86.00	Outperform
ANIK Anika Therapeutics	9/23/2025	Reiterated Rating	$9.27	$15.00	Outperform
VRME VerifyMe	8/14/2025	Boost Price Target	$0.93	$1.50	Outperform
SRDX Surmodics	8/11/2025	Reiterated Rating	$35.41		Market Perform
XRAY DENTSPLY SIRONA	8/8/2025	Lower Price Target	$12.88	$18.00	Outperform
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
HAE Haemonetics	8/8/2025	Lower Price Target	$55.49	$86.00	Outperform
USPH U.S. Physical Therapy	8/8/2025	Boost Price Target	$83.47	$103.00	Outperform
LMAT LeMaitre Vascular	8/6/2025	Upgrade	$85.60	$95.00	Outperform
HSIC Henry Schein	8/6/2025	Lower Price Target	$64.83	$78.00	Outperform
MMSI Merit Medical Systems	7/31/2025	Reiterated Rating	$82.96	$103.00	Outperform
ANIK Anika Therapeutics	7/31/2025	Lower Price Target	$8.10	$15.00	Outperform
XRAY DENTSPLY SIRONA	7/22/2025	Reiterated Rating	$15.84	$21.00	Outperform
LMAT LeMaitre Vascular	7/22/2025	Reiterated Rating	$80.92		Market Perform
HAE Haemonetics	7/11/2025	Reiterated Rating	$78.35	$95.00	Outperform
OPCH Option Care Health	7/10/2025	Reiterated Rating	$30.59	$38.00	Outperform
USPH U.S. Physical Therapy	7/1/2025	Reiterated Rating	$78.31	$98.00	Outperform
OFIX Orthofix Medical	6/23/2025	Upgrade	$10.34	$16.00	Strong-Buy
MODV ModivCare	5/12/2025	Reiterated Rating	$1.18		Market Perform
XRAY DENTSPLY SIRONA	5/12/2025	Boost Price Target	$15.81	$21.00	Outperform
ANIK Anika Therapeutics	5/12/2025	Lower Price Target	$11.64	$19.00	Outperform
HSIC Henry Schein	5/6/2025	Lower Price Target	$66.58	$86.00	Outperform
OPK OPKO Health	5/1/2025	Reiterated Rating	$1.34	$2.25	Outperform
OPCH Option Care Health	4/30/2025	Reiterated Rating	$30.69	$38.00	Outperform
MMSI Merit Medical Systems	4/25/2025	Lower Price Target	$94.67	$103.00	Outperform
OPCH Option Care Health	4/21/2025	Reiterated Rating	$32.09	$38.00	Outperform
MMSI Merit Medical Systems	4/11/2025	Reiterated Rating	$91.54	$111.00	Outperform
ANIK Anika Therapeutics	3/13/2025	Lower Price Target	$17.11	$20.00	Outperform
OPK OPKO Health	3/12/2025	Reiterated Rating	$1.80	$2.25	Outperform
VRME VerifyMe	3/7/2025	Lower Price Target	$0.72	$1.25	Outperform
MODV ModivCare	3/7/2025	Lower Price Target	$2.96	$6.00	Outperform
LMAT LeMaitre Vascular	2/28/2025	Downgrade	$99.91		Market Perform
USPH U.S. Physical Therapy	2/28/2025	Lower Price Target	$82.25	$98.00	Outperform
XRAY DENTSPLY SIRONA	2/28/2025	Lower Price Target	$16.61	$20.00	Outperform
OPK OPKO Health	2/28/2025	Reiterated Rating	$1.73	$2.25	Outperform
OPCH Option Care Health	2/27/2025	Boost Price Target	$33.15	$38.00	Outperform

HSIC Henry Schein	2/26/2025	Reiterated Rating	$75.82	$90.00	Outperform
MMSI Merit Medical Systems	2/26/2025	Lower Price Target	$100.45	$111.00	Outperform
HAE Haemonetics	2/7/2025	Lower Price Target	$62.95	$95.00	Outperform
HSIC Henry Schein	1/30/2025	Boost Price Target	$79.87	$90.00	Outperform
MMSI Merit Medical Systems	1/29/2025	Boost Price Target	$109.03	$115.00	Outperform
OPCH Option Care Health	1/14/2025	Boost Price Target	$28.26	$33.00	Outperform

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.